circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion

Yonggang Zhang, Hongling Yang, Yan Long, Yipeng Zhang, Ronggui Chen, Junzhu Shi, Jiying ChenScientific 2021 · DOI

Abstract

Preeclampsia (PE) is a severe pregnancy complication linked to impaired trophoblast invasion. This study investigates the role of N6-methyladenosine (m6A) modification on circular RNAs (circRNAs) in PE pathogenesis. Through m6A RNA sequencing of placental tissues, we identified a prevalence of increased m6A-modified circRNAs in PE. Specifically, we focused on circPAPPA2, which exhibits decreased expression despite increased m6A modification in PE placentas. Mechanistically, the methyltransferase METTL14 adds m6A tags to circPAPPA2, while the reader protein IGF2BP3 recognizes these tags to maintain RNA stability. In PE, reduced IGF2BP3 levels lead to circPAPPA2 degradation, inhibiting trophoblast invasion. Our findings highlight placental circRNA m6A modification as a critical regulatory mechanism in PE.

Introduction

Preeclampsia (PE) affects 3% to 8% of pregnancies worldwide and is a leading cause of maternal and neonatal morbidity. The condition is characterized by hypertension and multi-organ dysfunction, rooted in the failure of placental trophoblast cells to adequately invade the uterine wall and remodel maternal spiral arteries. While the importance of the placenta is well-established, the underlying molecular triggers remain partially understood.

N6-methyladenosine (m6A) is the most abundant internal modification in eukaryotic mRNA, regulating various aspects of RNA metabolism. Recent evidence suggests that m6A also modifies circular RNAs (circRNAs)—stable, covalently closed loops of non-coding RNA. This study aimed to map the m6A "methylome" of circRNAs in PE placentas and elucidate how these modifications influence disease progression, specifically through the regulation of circPAPPA2.

Results

The m6A Landscape of circRNAs in Preeclampsia

Using Methylated RNA Immunoprecipitation Sequencing (MeRIP-seq), we compared the m6A profiles of circRNAs in PE placentas versus healthy controls. We identified a significant shift in the m6A landscape. Specifically, 136 circRNAs showed upregulated m6A methylation, while 86 were downregulated in PE samples. These methylation peaks were primarily enriched in the 3’UTR and near start codons, suggesting a regulatory role in RNA stability or translation.

Global shifts in circRNA m6A methylation in PE placentas. (a, b) Venn diagrams of circRNAs identified in control (N) and PE (P) samples. (c) Number of differentially methylated circRNAs. (d) Heatmap of m6A peaks across samples.

circPAPPA2 Dysregulation and Trophoblast Invasion

Among the differentially methylated circRNAs, circPAPPA2 stood out. Despite having increased m6A levels in PE, its overall expression was significantly reduced. Functional assays in TEV1 trophoblast cells demonstrated that knocking down circPAPPA2 significantly impaired their invasive capacity. Conversely, overexpressing circPAPPA2 restored invasion, indicating its essential role in normal placental development.

Mechanistic Insights: The METTL14-IGF2BP3-circPAPPA2 Axis

We investigated the cause of the inverse relationship between m6A levels and circPAPPA2 expression. We found that METTL14 acts as the "writer" that adds m6A modifications to circPAPPA2. Under normal conditions, the "reader" protein IGF2BP3 binds to these m6A sites, stabilizing the circular RNA. In PE placentas, however, IGF2BP3 levels are markedly decreased. This deficiency prevents the stabilization of m6A-tagged circPAPPA2, leading to its rapid degradation. Stability assays confirmed that overexpressing IGF2BP3 extended the half-life of circPAPPA2 from 74 to 131 hours, while its knockdown reduced it to 45 hours.

Discussion

This study provides a novel perspective on PE pathology by identifying placental circRNA m6A modification as a key regulatory layer. The discovery of the METTL14/IGF2BP3/circPAPPA2 axis explains how epigenetic modifications can lead to the downregulation of critical RNAs despite increased methylation. Furthermore, the identification of internal ribosome entry sites (IRES) in circPAPPA2 suggests potential protein-coding functions that warrant further investigation.

While our findings are promising, the small sample size for initial sequencing and the lack of in vivo therapeutic testing are limitations. Future research should explore whether stabilizing the IGF2BP3-circPAPPA2 interaction could offer a new strategy for treating or preventing preeclampsia.

Conclusion

We have demonstrated that m6A-modified circRNAs, particularly circPAPPA2, play a vital role in trophoblast invasion. The dysregulation of the m6A "reader" IGF2BP3 in preeclampsia leads to the loss of circPAPPA2 stability, contributing to the pathogenesis of the disease. This work opens new avenues for understanding and potentially targeting the epigenetic drivers of pregnancy complications.

Summary updated

Abstract

Here, we performed N6-methyladenosine (m6A) RNA sequencing to determine the circRNA m6A methylation changes in the placentas during the pathogenesis of preeclampsia (PE). We verified the expression of the circRNA circPAPPA2 using quantitative reverse transcription-PCR. An invasion assay was carried out to identify the role of circPAPPA2 in the development of PE. Mechanistically, we investigated the cause of the altered m6A modification of circPAPPA2 through overexpression and knockdown cell experiments, RNA immunoprecipitation, fluorescence in situ hybridization and RNA stability experiments. We found that increases in m6A-modified circRNAs are prevalent in PE placentas and that the main changes in methylation occur in the 3'UTR and near the start codon, implicating the involvement of these changes in PE development. We also found that the levels of circPAPPA2 are decreased but that m6A modification is augmented. Furthermore, we discovered that methyltransferase‑like 14 (METTL14) increases the level of circPAPPA2 m6A methylation and that insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) maintains circPAPPA2 stability. Decreases in IGF2BP3 levels lead to declines in circPAPPA2 levels. In summary, we provide a new vision and strategy for the study of PE pathology and report that placental circRNA m6A modification appears to be an important regulatory mechanism.
BibTeX
@inproceedings{zhang2021circrna,
  author = {Yonggang Zhang and Hongling Yang and Yan Long and Yipeng Zhang and Ronggui Chen and Junzhu Shi and Jiying Chen},
  title = {{circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-03662-5},
}
Figure